Cargando…

APRIL is overexpressed in cancer: link with tumor progression

BACKGROUND: BAFF and APRIL share two receptors – TACI and BCMA – and BAFF binds to a third receptor, BAFF-R. Increased expression of BAFF and APRIL is noted in hematological malignancies. BAFF and APRIL are essential for the survival of normal and malignant B lymphocytes, and altered expression of B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreaux, Jérôme, Veyrune, Jean-Luc, De Vos, John, Klein, Bernard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662875/ https://www.ncbi.nlm.nih.gov/pubmed/19291294 http://dx.doi.org/10.1186/1471-2407-9-83

Ejemplares similares

Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features
por: Villard, Orianne, et al.
Publicado: (2020)

Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features
por: Villard, Orianne, et al.
Publicado: (2020)

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2013)

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
por: Caraux, Anouk, et al.
Publicado: (2012)

SULFs in human neoplasia: implication as progression and prognosis factors
por: Bret, Caroline, et al.
Publicado: (2011)

Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression
por: Li, Zixuan, et al.
Publicado: (2012)

Gene expression-based risk score in diffuse large B-cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2012)

Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors
por: Moreaux, J, et al.
Publicado: (2013)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2013)

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
por: Lamure, Sylvain, et al.
Publicado: (2020)

Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
por: Bou Samra, Elias, et al.
Publicado: (2014)

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
por: Vikova, Veronika, et al.
Publicado: (2019)

Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients
por: Bou Samra, Elias, et al.
Publicado: (2012)

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
por: Herviou, Laurie, et al.
Publicado: (2019)

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value
por: Viziteu, Elena, et al.
Publicado: (2016)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
por: Bruyer, Angelique, et al.
Publicado: (2018)

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
por: Mahtouk, Karène, et al.
Publicado: (2010)

Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
por: Devin, Julie, et al.
Publicado: (2022)

APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
por: Hahne, Michael, et al.
Publicado: (1998)

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
por: Simonneau, Marie, et al.
Publicado: (2018)

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
por: Ovejero, Sara, et al.
Publicado: (2021)

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer
por: He, Yuting, et al.
Publicado: (2018)

The role of prostate tumor overexpressed 1 in cancer progression
por: Cánovas, Verónica, et al.
Publicado: (2016)

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma
por: Kassambara, Alboukadel, et al.
Publicado: (2012)

Overexpression of WDR79 in non‐small cell lung cancer is linked to tumour progression
por: Sun, Yang, et al.
Publicado: (2016)

B7-H3 overexpression in pancreatic cancer promotes tumor progression
por: ZHAO, XIN, et al.
Publicado: (2013)

Geriatric slim implants for complete denture wearers: clinical aspects and perspectives
por: Huard, Cedric, et al.
Publicado: (2013)

Comprehensive CAD/CAM Prosthetic Rehabilitation Management in a Young Patient with Agenesis: A Case Report
por: Drancourt, Noémie, et al.
Publicado: (2022)

TRIM28 is overexpressed in glioma and associated with tumor progression
por: Su, Chunhai, et al.
Publicado: (2018)

Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression
por: Wang, Lili, et al.
Publicado: (2018)

Overexpression of TRIM24 Correlates with Tumor Progression in Non-Small Cell Lung Cancer
por: Li, Haiying, et al.
Publicado: (2012)

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013)

Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression
por: Zhang, Min, et al.
Publicado: (2013)

Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer
por: Li, Haiying, et al.
Publicado: (2013)

Predictive Parameters of Oral Health Quality of Life in Complete Mandibular Denture Wearers Stabilized by Mini-Implants: A Two-Year Follow-up Study
por: Batisse, Cindy, et al.
Publicado: (2017)

Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer
por: Huang, Xiaodong, et al.
Publicado: (2020)

Influence of the renewal of removable dentures on oral health related quality of life
por: Bonnet, Guillaume, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8qlc4b8ab4ortbrn8t8jhpbplk